Anupam Rasayan is India’s one of the leading companies. It deals in the custom synthesis and manufacturing of specialty chemicals in India. Anupam Rasayan is generally dealing mainly with agrochemicals. The company has two business segments which are life sciences specialty chemicals. It also deals in personal care and pharmaceuticals and various other specialty chemicals which are included in pigment, dyes, and polymer additives. It is also believed that this company has a strong and long-term relationship with various multinational corporations. All these MNCs include Syngenta Asia Pacific, Sumitomo Chemical, and UPL. Not only in India it deals in various other companies as well such as United States, Europe, and Japan. Recently it is found that Anupam Rasayan Share Price has opened at Rs 520 which is lower than the issue price. Let’s look over the details of its Share Price.
Anupam Rasayan Share Price
The company’s share price has opened with a 6.3% discount at NSE. As the share price was issued for Rs 555. Currently, this share price is trading at Rs 517.95 as of March 24, 2021. The stock listed at Rs 520 against the issue price of Rs 555 per share. At BSE this opening is stood at Rs 534.70 which is registered at a 3.6% loss. But it was believed by the analysts that this will debut with a 10-20% premium. It is believed that the company has garnered Rs 760 crore through its public issue which seen a subscription of 44.06 times during March 12-16, 2021.
Anupam Rasayan’s Revenue Revenue
The company has its major revenue from exports. As it was mentioned that it generally deals with some nations. So the company earns revenue of 35.97% from Europe, 17.23% from Singapore, 5.83% from Japan, 3.69% from U.S. India itself account for 31.95% of its revenue. This company grows at an annualized rate of 24.29% in FY18-29.
Valuation of the company
It was seen that this company has shown a tremendous performance. But now there are expectations that it will be able to gain more market share and simultaneously its margins will also improve. This company is expected to do well post listing going forward. It also has a strong financial position and has been generating positive cash flows.